NUTRIBAND INC. - COMMON STOCK

7.3800

20-February-25 15:45:00

15 minutes delayed

Stocks

+0.2000

+2.79%

Today's range

7.0009 - 7.4315

ISIN

N/A

Source

NASDAQ

Nutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

13 Feb 2025 06:00:00 By Nasdaq GlobeNewswire
Nutriband Inc. Announces Olympian Anastasia Nichita to Advisory Board

11 Feb 2025 08:00:00 By Nasdaq GlobeNewswire
Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™

07 Feb 2025 07:45:00 By Nasdaq GlobeNewswire
Nutriband Issues Letter to Shareholders

31 Dec 2024 06:00:00 By Nasdaq GlobeNewswire
Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology

27 Dec 2024 08:25:00 By Nasdaq GlobeNewswire
Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

04 Dec 2024 08:00:00 By Nasdaq GlobeNewswire
Nutriband Inc. to Present at The 2024 Noble Conference in Boca Raton on December 4th

04 Dec 2024 06:00:00 By Nasdaq GlobeNewswire
Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology

27 Nov 2024 06:00:00 By Nasdaq GlobeNewswire

<<
<
1
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.